Hypermarcas (HYPMY) Projected to Announce Quarterly Earnings on Wednesday

Hypermarcas (OTCMKTS:HYPMY) is anticipated to announce its results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of $0.14 per share and revenue of $466.4080 million for the quarter.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. The firm had revenue of $383.13 million during the quarter. On average, analysts expect Hypermarcas to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Hypermarcas Price Performance

Shares of OTCMKTS:HYPMY opened at $4.15 on Wednesday. The firm’s 50 day moving average price is $4.13 and its 200-day moving average price is $4.38. Hypermarcas has a twelve month low of $3.71 and a twelve month high of $5.50. The stock has a market capitalization of $2.92 billion, a PE ratio of 8.65 and a beta of 0.71.

Analyst Ratings Changes

A number of analysts have commented on HYPMY shares. Zacks Research raised shares of Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research note on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, Hypermarcas has a consensus rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.